DrugPatentWatch Database Preview
MEDROL ACETATE Drug Profile
» See Plans and Pricing
Which patents cover Medrol Acetate, and when can generic versions of Medrol Acetate launch?
Medrol Acetate is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in MEDROL ACETATE is methylprednisolone acetate. There are forty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.
US ANDA Litigation and Generic Entry Outlook for Medrol Acetate
A generic version of MEDROL ACETATE was approved as methylprednisolone acetate by TEVA PHARMS USA on February 23rd, 2005.
Summary for MEDROL ACETATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 29 |
| Patent Applications: | 2,727 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | MEDROL ACETATE at DailyMed |
US Patents and Regulatory Information for MEDROL ACETATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | MEDROL ACETATE | methylprednisolone acetate | OINTMENT;TOPICAL | 012421-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Pharmacia And Upjohn | MEDROL ACETATE | methylprednisolone acetate | OINTMENT;TOPICAL | 012421-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
